Epidemiology of neurodevelopmental disorders in 2 years old Georgian children. Pilot study - population based

Nino Tatishvili1, Maia Gabunia, Nino Laliani

  • 1Pediatric Neurology Department, Iashvili Children's Central Hospital, 0159 Tbilisi, Georgia. n_tatishvili@mail.ru

Insights

This study on 348 newborns found 8.5% had abnormal neurodevelopment by age two. Key risk factors for poor outcomes included maternal age and low Apgar scores at birth.

Area of Science:

  • Pediatrics
  • Neuroscience
  • Epidemiology

Background:

  • Neurodevelopmental disorders are a significant concern in early childhood.
  • Understanding the epidemiology and risk factors is crucial for early intervention.

Purpose of the Study:

  • To investigate the epidemiology of neurodevelopmental disorders in a regional infant population.
  • To identify key factors influencing neurodevelopmental outcomes up to two years of age.

Main Methods:

  • A cohort of 348 newborn infants was randomly selected from a regional population of 1272.
  • Neurological follow-up was conducted until the age of 24 months.
  • Data on neonatal pathologies and risk factors were collected and analyzed.

Main Results:

  • The incidence of abnormal neurodevelopment at 24 months was 8.5% (29 cases).
  • Common conditions included global developmental delay (1.5%), behavioral/sleep disorders (3.5%), and epilepsy (1.5%).
  • Frequent neonatal pathologies included low Apgar scores (3.5%) and neonatal sepsis (2.2%).

Conclusions:

  • Maternal age, chorioamnionitis, preterm birth (<37 weeks), pathological delivery, and low 5-minute Apgar scores were significant risk factors.
  • The presence of multiple risk factors amplified the likelihood of adverse neurodevelopmental outcomes.

Related Concept Videos